The Entrepreneurial Life Science Accelerator ELSA helps life science start-ups shape their business ideas to make them viable and propel them to the next level in the shortest possible time. As a continuation of the former AHEAD Life Science Track, the program is conducted by the Life Science Factory in collaboration with our partner Fraunhofer, Helmholtz Munich and H3 Health Hub. Selected life science start-ups receive free support in a condensed period of 3×2 days, focusing on technology, market and customer understanding, as well as strategy and investor outreach.
The accelerator program emphasizes individual coaching sessions with experts on specific topics such as financing models, intellectual property (IP), or pitch training. Through interactions among themselves and with our coaches, start-ups are empowered to advance their projects intensively. The program concludes with a pitch event in front of an expert and investor jury, as well as a wide audience. All components of our program are conducted in English.
For more Information about the next ELSA track click here
objectives of the ELSA program
→ Developing a viable business model and market validation
→ Creating a target-group-oriented pitch
→ Forming an entrepreneurial team
→ Enhancing business development and acquisition expertise
→ Establishing a network with relevant partners in the life science industry
→ Inspiration, learning within the community & having a fantastic time
Excerpt of the Coaches
Freelance Business Consultant Biotechnology, TGM Consult
Lawyer, Associate, Neuwerk
Head of Research, Eternygen GmbH
Corporate M&A, Business Development, Sartorius
Head of Center for Digital GreenTech, AWS Institut
Consultant, MedTech360
Managing Director, Arkadien Finanz GmbH
Life Sciences & Health Technology Specialist
Business Designer, Freelance Consultant
Lawyer, Associate, Neuwerk
Managing Director Business Consulting, white IP
Equity Management & Valuation, Ascenion
Scientific Opportunity Development
Life Science Valley Wachstumsfond
EIT Health
Life Science Factory
Helmholtz Munich
Flick Gocke Schaumburg
Winners of the last years
Avocet Bio claimed the Audience Award, earning the most votes with their innovative RNA-modulation platform, which aims to transform treatments for respiratory viral infections and beyond.
ASAP impressed the expert jury and secured the Jury Prize with their AI-driven histological image analysis, paving the way for faster and more precise insights in cardiovascular disease research.
Inhale+ is transforming inhalation therapy for preterm infants. Their innovative approach impressed our jury.
Fluorizon is a CRO specializing in high-yield radiolabeling for drug development. With this approach, they won the audience vote.
Advylop's PEG alternative retains production benefits while reducing allergies and side effects in chronic disease treatments.
partner
